Article
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2005
Li Donghui, Ahmed Maha, Li Yanan, Jiao Li, Chou Ta-Hsu, Wolff Robert A, Lenzi Renato, Evans Douglas B, Bondy Melissa L, Pisters Peter W, Abbruzzese James L, Hassan Manal M
Abstract excerpt
To test the hypothesis that 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms modify the risk of pancreatic cancer, we conducted a hospital-based, case-control study involving 347 patients with newly diagnosed pancreatic adenocarcinoma and 348 healthy controls, frequency matched by age, sex, and race. MTHFR polymorphisms were determined using the PCR-RFLP method. Association of these polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.